Trial Profile
A Single-Center, Open-Label Study of Excretion Balance, Pharmacokinetics, and Metabolism of 14C-Labeled Tozadenant After 240 mg Single Oral Dose Administration in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Aug 2017
Price :
$35
*
At a glance
- Drugs Tozadenant (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors UCB Pharma SA
- 18 Sep 2014 New trial record